Medincell Obtains EUR14 Million in Additional Non-dilutive Financing

MT Newswires · 2d ago
12:50 AM EDT, 10/14/2026 (MT Newswires) -- Medincell (MEDCL.PA) secured 13.8 million euros of additional non-dilutive financing on market terms, according to a Tuesday filing. The biopharmaceutical company said it obtained the financing from Bpifrance and unnamed European commercial banks. Medincell's debt maturity profile has been extended to September 2031.